跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tagrisso - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tagrisso
Approved
STANDARD
Tagrisso
AstraZeneca AB
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
280dbe3e78c13458
Company
AstraZeneca AB
Type
Standard
Approval Details
Approval Id
280dbe3e78c13458
Drug Approval Philippines Name
Tagrisso
Product Name
Tagrisso
Registration Number
DR-XY45878
Brand Name
Tagrisso
Generic Name
Osimertinib (as mesylate)
Dosage Form
Film-Coated Tablet
Dosage Strength
80 mg
Manufacturer
AstraZeneca AB
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Distributor
AstraZeneca Pharmaceuticals (Phils.), Inc.
Company Detail Path
/organization/astrazeneca-ab
Issuance Date
29 August 2023
Expiry Date
29 August 2028
Pharmacologic Category
Protein Kinase Inhibitors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
280dbe3e78c13458
Type
Standard
Back to Philippines FDA Approvals